DigitalHealth.Rx

10 - Thought Leaders Assembly – Catalyzing Pharmacy’s Future (presentations and breakout discussion sprints)

Thursday, March 11, 2021

4:35 PM – 6:20 PM ET

Location: Live

CE: 0

Presenter(s)

Ilisa Bernstein, PharmD, JD, FAPhA

Senior Vice President, Pharmacy Practice & Government Affairs
American Pharmacists Association
Washington, District of Columbia, United States

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Megan Coder, PharmD, MBA

Executive Director
Digital Therapeutics Alliance
Arlington, Virginia, United States

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Steven W. Chen, PharmD

Associate Dean for Clinical Affairs
University of Southern California School of Pharmacy
South Pasadena, California, United States

Disclosure: Otsuka America Pharmaceuticals: Speaker's Bureau

Presentation PDF
Yoona Kim, PharmD, PhD

CEO
Arine Inc.
San Francisco, California, United States

Disclosure: Arine Inc.: Employment, Ownership Interest
David N. Berkowitz, PharmD

Pharmacy Consultant
Omnicell
Needham Heights, Massachusetts, United States

Disclosure: Omnicell: Employment, Ownership Interest

Presentation PDF
Shelly Spiro, RPh, BSPharm, FASCP

Executive Director
Pharmacy HIT Collaborative
Washington , District of Columbia, United States

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Adrijana Kekic, PharmD

Pharmacogenomics Clinical Specialist
Mayo Clinic

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation PDF
Komal Patel, PharmD

Clinical Pharmacist, Product Development
Catalia Health
Brea, California, United States

Disclosure: Catalia Health: Employment, Ownership Interest

Presentation PDF
Lucinda Maine, PhD

EVP and CEO
American Association of Colleges of Pharmacy
Arlington, Virginia, United States

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation PDF
Kevin B. Sneed, PharmD, FNPHA, FNAP

Sr. Associate VP, USF Health and Dean, Taneja College of Pharmacy
USF Health Taneja College of Pharmacy, University of South Florida
Tampa, Florida, United States

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Sandra Leal, PharmD, MPH,FAPhA, CDCES

EVP
Tabula Rasa HealthCare
Tucson, Arizona, United States

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation PDF
Randy P. McDonough, PharmD, MS, BCBP, BCPS

Co-Owner
Towncrest Pharmacies
Iowa City, Iowa, United States

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Rajan Vaidya, PharmD

Vice President, Practice & Professional Development
California Pharmacists Association
Sacramento, California, United States

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Smit Patel, PharmD

Director of Digital Medicine
Digital Medicine Society (DiMe)
Columbus, Ohio, United States

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Arlin Ashemore, PharmD MS

Automation Research and Outcomes Fellow
Omnicell
Mountain View, California, United States

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Christy Cheung, PharmD

Medical Science Liaison
Sanofi Genzyme
Toronto, Ontario, Canada

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Ellen Berkley, PharmD Candidate

Student Pharmacist
University of California, San Francisco

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Jonathan Little, PharmD

Executive Fellow
American Pharmacists Association Foundation
Oklahoma City, Oklahoma, United States

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Parisa Vatanka, PharmD, CTTS

Senior Director Corporate Alliances and Chair, DigitalHealth.Rx
American Pharmacists Association
San Ramon, California, United States

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Timothy Aungst, PharmD

Associate Professor of Pharmacy Practice
MCPHS University
JEFFERSON, Massachusetts, United States

Disclosure: GoodRx: Consultant/Advisory Board; Otsuka: Consultant/Advisory Board, Speaker's Bureau; Teva Pharmaceuticals: Speaker's Bureau

One of the highlights of APhA’s inaugural digital health summit is the Thought Leaders Assembly. During this interactive session, we will hear presentations from experts in pharmacy transformation and digital health integration. Participants will have the opportunity to customize their experience by selecting their preferred breakout discussion sprint – we want to hear participants’ perspectives as we take steps toward digital health integration in pharmacy.

The aim is to consider the current healthcare landscape and discuss opportunities, needed resources, and next steps to successfully transition to new practice norms where digital health products and solutions are seamlessly integrated into the care we provide. The tempo for the six presentations and breakout discussion sprints will be a quick pace as it is meant to be rich on content while also being a super-engaging virtual experience.

Presentation 1: Policy and Regulatory Considerations - Ilisa Bernstein and Megan Coder
Digital therapeutic products offer solutions to policy leaders focused on healthcare as they search for new ways to address increasing mental health challenges caused or exacerbated by COVID-19, enable patients with chronic diseases to control their conditions outside of traditional office settings, and reduce unnecessary burdens placed on over-taxed clinicians and healthcare organizations. Policymakers at the local, national, and regional levels are therefore facing a number of important questions related to the regulatory recognition of digital therapeutic products and legislative actions necessary to enable public payor coverage and patient access. During this session, we'll take a closer look at the U.S. regulatory and legislative landscape.

Presentation 2: Value-Based Models - Digital Health Partnerships - Steven Chen and Yoona Kim
The California Right Meds Collaborative is a consortium of health plans, pharmacies, academic and professional organizations in the Southern California region to deliver high impact Comprehensive Medication Management services through a sustainable, value-based payment model. Learn about this collaborative and how CRMC is partnering with Arine to scale their services using Arine's Virtual Pharmacist software platform.

(Breakout Discussion Sprint #1)

Presentation 3: The Digital Care Transformation of Pharmacy - David Berkowitz and Shelly Spiro
Internet of Things (IoT) devices to conduct remote patient monitoring offer the promise of an entirely new pharmacy care delivery model.  Data standards, the organization of data and the ability to share codified data in a standard way as part of a patient’s comprehensive care team will lead to the ability to more easily measure outcomes and ultimately drive the creation of intelligence layers digitally transforming clinical care by pharmacists.

Presentation 4: Medication Optimization Leveraging Advanced Technologies - Adrijana Kekic and Komal Patel
This session will give you an understanding of how technology is being leveraged in practice settings to provide data driven insights that lead to optimization of the medication treatment plan. Come learn how pharmacogenomics, connected devices, conversational AI, and other accessible data streams are converging to create personalized medicine.

(Breakout Discussion Sprint #2)

Presentation 5: Pharmacist Education and Training – Preparing for Emerging Roles - Lucinda Maine and Kevin Sneed
Participants in this session will offer suggestions to increase the integration of digital health content in both PharmD and post-graduate pharmacists’ education. Prioritizing the most urgent focus to enhance pharmacists’ contributions to and use of digital health tools will be the heart of the discussion.

Presentation 6: Practice Implementation – Strategies and Collaborations - Sandra Leal and Randy McDonough
Technology is being used to transform community-based pharmacy practice to optimize patient care as it relates to medication management. Sharing of patient data between providers, payers, and other stakeholders is positively impacting patient outcomes. Join this discussion about the value of partnership between community-based pharmacies and healthcare companies to leverage technology and patient reach to impact population health.

(Breakout Discussion Sprint #3)